Pura Vida Investments, LLC Zymeworks Inc. Transaction History

Pura Vida Investments, LLC

  • $145 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$4.82 - $7.7 $215,434 - $344,159
44,696 New
44,696 $237,000
Q3 2020

Nov 16, 2020
SELL
$29.21 - $46.58 $598,805 - $954,890
-20,500 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$33.67 - $40.0 $690,235 - $820,000
20,500 New
20,500 $739,000
Q4 2019

Feb 14, 2020
SELL
$24.84 - $45.46 $1.24 Million - $2.27 Million
-50,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$22.78 - $29.08 $1.14 Million - $1.45 Million
50,000 New
50,000 $1.24 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $903M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email